State Ledger
Company profile

BioCardia, Inc. CIK 925741

Ticker
BCDA (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Sunnyvale, CA 94085
Fiscal year end
2025 (FY)
Market Data
Close
$1.03
Change
-$0.02
Change %
-1.90%
Volume
2,423

BCDA · trading date Oct 9, 2026 · previous close $1.05 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$8.23M
Total assets
$3.41M
Total liabilities
$2.52M
Stockholders' equity
$895.0K
Cash & equivalents
$2.50M
Operating income
-$8.28M
Operating cash flow
-$7.44M
Capital expenditures
$7.0K

Fiscal year 2025, via 10-K filed 2026-03-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$7.44M
Free cash flow margin
—
Liabilities / assets
73.8%
Equity / assets
26.2%
CapEx / revenue
—
Operating cash flow / net income
0.90×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$8.23M $3.41M $2.52M $895.0K
2024 — -$7.95M $3.72M $2.89M $837.0K
2023 — -$11.57M $2.99M $4.59M -$1.60M
2022 — -$11.91M $9.79M $4.90M $4.89M
2021 — -$12.62M $15.72M $5.34M $10.38M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-10
Financials filed via
Form 10-K
filed 2026-03-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Sunnyvale, CA 94085
320 SOQUEL WAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:14 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies